Vigorous exercise program

Suggested

3 studies · 1 recommendation

Last updated: February 25, 2026

Vigorous exercise program – Prostate Cancer
Suggested3 studies

Vigorous exercise reduces prostate cancer risk and improves outcomes after treatment

Three studies encompassing over 7,700 men consistently link vigorous physical activity to prostate cancer benefits. Two cluster RCTs (n=147) of men who completed prostate cancer treatment found that a clinician-referred 12-week exercise program significantly increased vigorous activity (Cohen's d=0.46; 95% CI 0.09–0.82; P=0.010), with exercisers nearly four times more likely to meet the ≥150 minutes/week guideline (OR=3.9; P=0.002). Notably, only vigorous-intensity activity drove the benefit—combined moderate-vigorous exercise showed no significant effect. A prospective cohort study (n=7,588; 18.8-year follow-up) confirmed a significant dose-response reduction in prostate cancer risk specifically at moderately-vigorous or vigorous activity levels, with no benefit from lighter activity. Depression symptoms also trended toward improvement (d=−0.35; P=0.06). Structured programs with supervised sessions followed by independent gym-based exercise offer a practical framework for sustaining vigorous activity.

Evidence

Authors: Courneya, KS, Craike, Melinda, Gaskin, CJ, Livingston, PM, Mohebbi, M

Published: May 1, 2017

In the ENGAGE multicenter cluster randomized controlled trial, 147 men with prostate cancer were allocated to a clinician referral plus 12-week exercise training program (n=54) or usual care (n=93). A statistically significant positive interaction effect for vigorous physical activity was observed at 6 months post-randomization. However, this effect was not sustained at 12 months. The intervention included supervised and unsupervised community-based exercise sessions followed by discounted gym membership. No significant effects were found for secondary outcomes including quality of life, anxiety, or depressive symptoms.

Authors: Botti, Mari, Broadbent, Suzanne, Courneya, Kerry S, Craike, Melinda J, ENGAGE Uro-Oncology Clinicians\u27 Group,, Fraser, Steve F, Gaskin, Cadeyrn J, Kent, Bridie, Livingston, Patricia M, Mohebbi, Mohammadreza, Salmon, JO

Published: January 1, 2015

A cluster RCT with 147 men who completed active prostate cancer treatment demonstrated that vigorous-intensity exercise yielded a significant intervention effect (Cohen's d=0.46; 95% CI 0.09–0.82; P=0.010). Meeting the exercise guideline threshold of ≥150 minutes per week was significantly more likely in the exercise group (OR=3.9; 95% CI 1.9–7.8; P=0.002). Combined moderate and vigorous exercise did not reach significance (d=0.08; 95% CI −0.28 to 0.45; P=0.48), suggesting that vigorous-intensity activity specifically drives the benefit. Depression symptom improvement approached significance (d=−0.35; P=0.06).

Authors: A G Shaper, Albanes D, Bennett A, Cox DR, Gerhardsson L, Giovannucci E, Giovannucci E, Hackney AC, Hartman TJ, Kampert JB, Lee I-M, Lee I-M, Lee I-M, Lee I-M, Liu S, M Walker, McTiernan A, Moore MA, Oliveria SA, Oliveria SA, Paffenbarger RS, Reddy BS, S G Wannamethee, Severson RK, Shaper AG, Shaper AG, Shaper AG, Shephard RJ, Singh P, Slattery ML, Taylor HL, Thune I, Thune I, Thune I, Walker M, Weiderpass E, Wilson PWF

Published: November 2, 2001

Prospective cohort study of 7,588 men aged 40–59 years followed for a mean of 18.8 years, during which 969 cancers developed (excluding skin cancers). After adjustment for age, smoking, body mass index, alcohol intake, and social class, sporting activity was associated with a significant dose-response reduction in prostate cancer risk. Only moderately-vigorous or vigorous activity levels achieved significant benefit; no reduction was observed at lesser activity levels. Non-sporting recreational activity showed no association with cancer risk.